The Good News About Cancer

The Good News About Cancer
Podcast Description
Did you know that “good news” and “cancer” could go together? The truth is, patients and their families have never had more reasons for hope and optimism than they do right now. A decade of transformational breakthroughs in treatment and prevention have saved millions of lives, and that’s just the beginning. In every episode of The Good News About Cancer, Dr. Charles Ryan and Dr. Alicia Morgans speak to the doctors, researchers, and advocates who are improving outcomes and charting new paths forward all around the world. Now that’s good news!
Podcast Insights
Content Themes
The show focuses on transformative breakthroughs in cancer treatment and prevention, with episodes highlighting topics like recent advancements in immunotherapy and the importance of early detection. A significant example includes their discussion with Karen Knudsen, addressing key wins in cancer care and the progress made by the American Cancer Society.

Did you know that “good news” and “cancer” could go together? The truth is, patients and their families have never had more reasons for hope and optimism than they do right now. A decade of transformational breakthroughs in treatment and prevention have saved millions of lives, and that’s just the beginning. In every episode of The Good News About Cancer, Dr. Charles Ryan and Dr. Alicia Morgans speak to the doctors, researchers, and advocates who are improving outcomes and charting new paths forward all around the world. Now that’s good news!

Before the early 2000s, there were no effective treatments for chronic myelogenous leukemia, a blood cancer. Then came Imatinib. This drug dramatically improved survival and quality of life for patients with this disease. It also ushered in a new era of cancer treatment, with drugs that directly target tumor cells. In this episode, Chuck and Alicia talk with Dr. Brian Druker, a renowned physician scientist who was the main force behind the development of Imatinib.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.